Release 5.9.0: Saved Query Alerts, Query Details, Collection Sizes and more!

Saved Query Alerts.

Receive a notification email when new data is added for your saved queries.

Query Details Improvements.

View details of your joined query when navigating between cited/citing panes.

Collection Limit Increase.

Create collections of up to 50,000 Patents or Scholarly Works.

Assay Method For Alzheimer's Disease


The full document isn't yet available to us from the patent office.


A diagnostic test for preclinical and clinical Alzheimer's disease is based on plasma levels of A² 40 , A² 42 , their ratio, or their rate of entry following administration of antibodies that sequester A². Alterations of any of these parameters from control values identifies preclinical or clinical Alzheimer's disease.


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jul 16, 2008
  • Application: Aug 16, 2002
    EP EP 07024341 A
  • Priority: Aug 16, 2002
    EP EP 02766022 A
  • Priority: Oct 23, 2001
    US US 33498701 P
  • Priority: Aug 17, 2001
    US US 31322101 P

Sign in to the Lens